OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
147 hedge funds and large institutions have $654M invested in Orexigen Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 32 increasing their positions, 51 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
15% more funds holding
Funds holding: 128 → 147 (+19)
37% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 51
Holders
147
Holding in Top 10
4
Calls
$10.2M
Puts
$8.6M
Top Buyers
| 1 | +$20.6M | |
| 2 | +$11.5M | |
| 3 | +$7.89M | |
| 4 |
Morgan Stanley
New York
|
+$6.38M |
| 5 |
Millennium Management
New York
|
+$5.73M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$10.1M | |
| 3 | -$9.5M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.97M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$4.53M |